Meta-analysis of the efficacy of escitalopram and citalopram in the treatment of major depressive disorder.

被引：0
|
作者：
Kasper, S
Auquier, P
Robitail, S
Llorca, PM
Rive, B
机构：
[1] Med Univ Vienna, Vienna, Austria
[2] Fac Med, Marseille, France
[3] Ctr Hosp Univ, Clermont Ferrand, France
来源：
NORDIC JOURNAL OF PSYCHIATRY | 2005年 / 59卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：413 / 413
页数：1
相关论文
共 50 条
  • [41] The safety and efficacy of vortioxetine for acute treatment of major depressive disorder: A systematic review and meta-analysis
    Meeker A.S.
    Herink M.C.
    Haxby D.G.
    Hartung D.M.
    [J]. Systematic Reviews, 4 (1)
  • [42] Cost-effectiveness of escitalopram vs. citalopram in major depressive disorder
    Fantino, Bruno
    Moore, Nicholas
    Verdoux, Helene
    Auray, Jean-Paul
    [J]. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2007, 22 (02) : 107 - 115
  • [43] Efficacy of escitalopram in the treatment of social anxiety disorder: A meta-analysis versus placebo
    Baldwin, David S.
    Asakura, Satoshi
    Koyama, Tsukasa
    Hayano, Taiji
    Hagino, Atsushi
    Reines, Elin
    Larsen, Klaus
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2016, 26 (06) : 1062 - 1069
  • [44] Escitalopram in major depressive disorder:: clinical benefits and cost effectiveness versus citalopram
    Lancon, Christophe
    Verpillat, Patrice
    Annemans, Lieven
    Despiegel, Nicolas
    Francois, Clement
    [J]. INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 2007, 11 (01) : 44 - 52
  • [45] Zuranolone for treatment of major depressive disorder: a systematic review and meta-analysis
    Ahmad, Abdullah
    Awan, Abdul Rafeh
    Nadeem, Natasha
    Javed, Aamir Shahid
    Farooqi, Mobeen
    Daniyal, Muhammed
    Mumtaz, Hassan
    [J]. FRONTIERS IN NEUROSCIENCE, 2024, 18
  • [46] Efficacy of inpatient psychotherapy for major depressive disorder: a meta-analysis of controlled trials
    Schefft, C.
    Guhn, A.
    Brakemeier, E. -L.
    Sterzer, P.
    Koehler, S.
    [J]. ACTA PSYCHIATRICA SCANDINAVICA, 2019, 139 (04) : 322 - 335
  • [47] DATA-DRIVEN LEARNING ANALYSIS IDENTIFIES GENDER DIFFERENCES IN METABOLIC TREATMENT RESPONSE OF CITALOPRAM/ESCITALOPRAM IN MAJOR DEPRESSIVE DISORDER
    Athreya, A. P.
    Neavin, D.
    Bobo, W. V.
    Frye, M. A.
    Skime, M.
    Kaddurah-Daouk, R.
    Rush, A. J.
    Matson, W.
    Iyer, R. K.
    Wang, L.
    Weinshilboum, R. M.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2017, 101 (S1) : S18 - S18
  • [48] Escitalopram in acute treatment of children and adolescents with major depressive disorders: A meta-analysis and systematic review
    Maneeton, N.
    Maneeton, B.
    Puthisri, S.
    Woottiluk, P.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2019, 29 : S362 - S363
  • [49] Efficacy of escitalopram monotherapy in the treatment of major depressive disorder A pooled analysis of 4 Chinese clinical trials
    Li, Guanjun
    Shen, Yifeng
    Luo, Jianfeng
    Li, Huafang
    [J]. MEDICINE, 2017, 96 (39)
  • [50] The efficacy and safety of adjunctive intranasal esketamine treatment in major depressive disorder: a systematic review and meta-analysis
    Jawad, Muhammad Youshay
    Di Vincenzo, Joshua D.
    Ceban, Felicia
    Jaberi, Saja
    Lui, Leanna M. W.
    Gillissie, Emily S.
    Alnafeesi, Yazen
    Rosenblat, Joshua D.
    McIntyre, Roger S.
    [J]. EXPERT OPINION ON DRUG SAFETY, 2022, 21 (06) : 841 - 852
12345